Clinical Trial Update: Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating trimethoprim/sulfamethoxazole for Pneumocystis pneumonia prophylaxis in patients with connective tissue diseases; curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Disease
• Pneumocystis Pneumonia

Drugs mentioned

• Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Pneumonia, Pneumocystis, Prevention & Control | Phase 2, Phase 3 | Status: UNKNOWN